Travis Hanson, MD
Pulmonary Disease · Sioux Falls, SDNPI 1700197498
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $279 of the $325 with a category attached, or 85.8%. 7 manufacturers reported payments, led by GSK at 43.4% of the total. Reporting peaked in 2023 at $129 and has fallen 70.2% since, to $38 in 2025. That places this record below the midpoint for pulmonary disease clinicians in SD, where the typical reported total is $424.
Across 25 payments — averaging $13.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$141
- Intuitive Surgical$86
- Insmed, Inc.$34
- Inspire Medical Systems, Inc.$21
- Sanofi$18
- Merck$13
- plus $13 from 1 others
What the payments were for
- Food & beverage$27986%
- Education$4614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $141 |
| Intuitive Surgical | 1 | $86 |
| Insmed, Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Sanofi | 1 | $18 |
| Merck | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
How this compares
$325 in reported general payments places this provider in the 45th percentile of 35 pulmonary disease providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 22 | $253,594 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 283 | $179,791 |
| GlassiaAlpha-1-Proteinase Inhibitor | 13 | $173,364 |
| NucalaMepolizumab | 15 | $166,474 |
| Dupixent PenDupilumab | 19 | $67,393 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 120 | $65,126 |
| Breo ElliptaFluticasone/Vilanterol | 148 | $60,824 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 94 | $46,915 |
| Spiriva RespimatTiotropium Bromide | 70 | $41,196 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 52 | $31,924 |
| Incruse ElliptaUmeclidinium Bromide | 76 | $28,825 |
| Pirfenidone | 23 | $25,314 |
| DuleraMometasone/Formoterol | 74 | $25,019 |
| Arnuity ElliptaFluticasone Furoate | 71 | $17,238 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $10,631 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $141 | $518,278713 claims |
| MerckDulera | $13 | $25,01974 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 35 pulmonary disease providers in South Dakota.
Other pulmonary disease in Sioux Falls
- Joevasanth DevasahayamSioux Falls$8K
- Matthew TaylorSioux Falls$8K
- Fady JamousSioux Falls$6K
- Rizan HajalSioux Falls$5K
- Kaitlin BranickSioux Falls$5K
- Anna PlemmonsSioux Falls$3K
- Mohammed AwadSioux Falls$2K
- Ashraf ElshamiSioux Falls$2K
- John YuSioux Falls$2K
- Rajaganesh RajagopalanSioux Falls$964
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.